首页 | 本学科首页   官方微博 | 高级检索  
     


Efficacy and safety of adalimumab in Chinese patients with moderate‐to‐severe plaque psoriasis: results from a phase 3, randomized,placebo‐controlled,double‐blind study
Authors:L. Cai  J. Gu  J. Zheng  M. Zheng  G. Wang  L.‐Y. Xi  F. Hao  X.‐M. Liu  Q.‐N. Sun  Y. Wang  W. Lai  H. Fang  Y.‐T. Tu  Q. Sun  J. Chen  X.‐H. Gao  Y. Gu  H.D. Teixeira  J.‐Z. Zhang  M.M. Okun
Affiliation:1. Peking University People's Hospital, Beijing, China;2. Shanghai Changhai Hospital, Shanghai, China;3. Ruijin Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai, China;4. Second Affiliated Hospital Zhejiang University College of Medicine, Hangzhou, China;5. The first Affiliated Hospital of Fourth Military Medical University, PLA (Xijing Hospital), Xi'an, China;6. Sun Yat‐sen Memorial Hospital, Sun Yat‐sen University, Guangzhou, China;7. The First Affiliated Hospital of Third Military Medical University, PLA (Southwest Hospital), Chongqing, China;8. First Affiliated Hospital of Dalian Medical University, Dalian, China;9. Peking Union Medical College Hospital, Beijing, China;10. Peking University First Hospital, Beijing, China;11. The Third Affiliated Hospital of Sun Yat‐sen University, Guangzhou, China;12. The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, China;13. Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China;14. Qilu Hospital of Shandong University, Jinan, China;15. Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, China;16. The First Hospital of China Medical University, Shenyang, China;17. AbbVie Inc., North Chicago, IL, USA;18. Fort HealthCare, Fort Atkinson, WI, USA
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号